Achieve faster product releases with Ketryx's validated AI agents

This article originally appeared in Today's Medical Developments on May 2, 2025.

Ketryx announced the launch of the first validated AI agents for regulated industries. This industry-first set of validated agents will transform how highly regulated companies design, develop, and deploy new products to market. Ketryx’s risk-based agents maintain human-in-the-loop oversight for safety-critical decision-making, so regulated teams can leverage the power of AI to generate documentation and accelerate product delivery.

“Highly regulated companies face a complicated paradox today: the systems and processes in place to ensure safety also weigh them down to the point where product teams across AI, software, and hardware spend most of their time on documentation and compliance instead of innovation,” says Erez Kaminski, CEO and founder of Ketryx. "We built Ketryx so quality and product development teams can harness the power of AI, a power so impactful it is the equivalent of tens of thousands of round-the-clock workers perpetually sifting through every piece of incoming data to ensure that patient-critical devices receive the most updated software as quickly and responsibly as possible."

These AI agents will address the traditional pain points that regulated teams face when developing products, such as manual documentation, tedious change management processes, and the complexity of fragmented systems. For example, when tens of thousands of requirements, test cases, risks, and quality procedures live in different tools, it’s extremely difficult to control for conflicts, ensure process adherence, and create traceability.